Biofilm remains one of the most persistent challenges in chronic wound care—reforming in just 12 to 24 hours. It evades the immune system and drastically reduce the effectiveness of antimicrobials.
In a new video, Dr Nicoletta Frescos shares key insights from the recently released: 📄 Autolytic Continuous Debridement with a Focus on Biofilm: Consensus Document for the APAC Region
This important document reflects the collective expertise of an APAC-based panel of clinicians, addressing the unique challenges faced in the region and promoting a more proactive and continuous approach to wound bed preparation.
🔑 Key Takeaways from the Consensus:
- Continuous autolytic debridement plays a vital role in managing biofilm between physical debridement sessions
- It complements other modalities to maintain a prepared wound bed
- Supports healing progression, reduces risk of infection, and enhances patient outcomes
- It is particularly relevant for APAC healthcare settings where access to regular debridement may vary
Autolytic continuous debridement with a focus on biofilm management:
Consensus document for the APAC region – Wounds International
📽️ Watch the video to hear Dr Frescos explain why autolytic debridement is an essential tool in the clinician’s wound care toolkit.
URGO Partners with Diabetes Feet Australia
URGO Medical is very excited to announce a partnership with Diabetes Feet Australia.
As part of their charter DFA have been working to develop evidence-based Australian guidelines for diabetes-related foot disease to serve as the new national multi-disciplinary best practice standards of care for the provision of DFD care within Australia.
These implementation initiatives are designed to help busy multi-disciplinary health care professionals use local guideline-recommended DFD care at any time and place. Urgo Medical Australia is proud to partner in this local initiative.
To support the launch of the guidelines, we will be working with DFA on a number of educational tools for HCPs practicing in this space including an educational webinar series and fact sheets for both HCPs and patients.
Other news
Managing Biofilm in Chronic Wounds: The Asia-Pacific (APAC) Consensus You Need to know
Discover more
Save Feet, Save Lives website launched
The Save Feet, Save Lives website includes information for patients about the diabetic foot complication and how to prevent and manage it.
Discover moreAsia Pacific – Diabetic Foot Disease Grant – 2021
ASIA PACIFIC – Diabetic Foot Disease Grant
Urgo Foundation is is pleased to offer a Diabetic Foot Disease Grant in 2021 to support Innovative Projects aiming at improving Diabetic Foot Ulcer Prevention and Management in the Asia Pacific Region.
Projects can be submitted by Healthcare Professionals, Researchers and Healthcare or Engineering Students working in the DFD field.
Proposed Projects should focus on innovation in DFD Prevention and Management, let your imagination flow!
Grants between 5,000€ & 10,000€ will be awarded, depending on the needs of each project.
The Deadline for submitting an application is September 30th 2021.
For more information, visit: https://fondation-urgo.com/2021/05/05/apac-dfd-grants/
Other news
Managing Biofilm in Chronic Wounds: The Asia-Pacific (APAC) Consensus You Need to know
Discover more
Save Feet, Save Lives website launched
The Save Feet, Save Lives website includes information for patients about the diabetic foot complication and how to prevent and manage it.
Discover moreSave Feet, Save Lives website launched
A WORLDWIDE DIABETIC FOOT PROGRAM TO SUPPORT CLINICIANS AND PATIENTS TO
CLOSE WOUNDS, SAVE FEET AND SAVE LIVES
To fulfill its mission as The Healing Company, Urgo Medical has made diabetic foot ulcer a key priority, with the aim to close wounds, save feet and save lives for patients with diabetes and eradicate amputations and death as a consequence of diabetic foot.
Other news
Managing Biofilm in Chronic Wounds: The Asia-Pacific (APAC) Consensus You Need to know
Discover more
